A Single Histrelin Implant Is Effective for 2 Years for Treatment of Central Precocious Puberty
| dc.contributor.author | Lewis, Katherine A. | |
| dc.contributor.author | Goldyn, Andrea K. | |
| dc.contributor.author | West, Karen W. | |
| dc.contributor.author | Eugster, Erica A. | |
| dc.contributor.department | Pediatrics, School of Medicine | |
| dc.date.accessioned | 2025-05-06T10:42:55Z | |
| dc.date.available | 2025-05-06T10:42:55Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | We investigated whether a "yearly" histrelin implant would provide pubertal suppression when left in place for 2 years. Equivalent suppression was observed when comparing 12 and 24 months in 33 children with central precocious puberty. A single implant for 2 years reduces cost and number of implant procedures. | |
| dc.eprint.version | Author's manuscript | |
| dc.identifier.citation | Lewis KA, Goldyn AK, West KW, Eugster EA. A single histrelin implant is effective for 2 years for treatment of central precocious puberty. J Pediatr. 2013;163(4):1214-1216. doi:10.1016/j.jpeds.2013.05.033 | |
| dc.identifier.uri | https://hdl.handle.net/1805/47785 | |
| dc.language.iso | en_US | |
| dc.publisher | Elsevier | |
| dc.relation.isversionof | 10.1016/j.jpeds.2013.05.033 | |
| dc.relation.journal | The Journal of Pediatrics | |
| dc.rights | Publisher Policy | |
| dc.source | PMC | |
| dc.subject | Central precocious puberty | |
| dc.subject | Gonadotropin releasing hormone analog | |
| dc.subject | Hypothalamic-pituitary-gonadal | |
| dc.subject | Luteinizing hormone | |
| dc.subject | Ultrasensitive | |
| dc.title | A Single Histrelin Implant Is Effective for 2 Years for Treatment of Central Precocious Puberty | |
| dc.type | Article |